1,667 Views
Cross-Cutting
Brain Injury
Stroke
Symposium
Maheen Adamson, PhD
Senior Scientific Research Director/Clinical Associate Professor
DVBIC, VA Palo Alto/Neurosurgery, Stanford School of Medicine
Palo Alto, California
Steven Cramer, MD
Professor, Department of Neurology
University of California, Los Angeles
Los Angeles, California
E. Alison Holman, PhD, FNP
Associate Professor
University of California-Irvine
Irvine, California
Laila Abdullah, PhD
Scientist III
Roskamp Instiute
Sarasota, Florida
Neuroplasticity is an important element of rehabilitation that can drive treatment planning in brain injury including stroke. It is driven by genetic and proteomic factors and incorporating both at the level of diagnosis and treatment can provide useful information at various time-points to determine focus, interventions, and progress towards overall goals and objectives. We will explore several avenues in depth in this symposium to incorporate both fluid and genetic biomarkers in diagnosis and interventions that impact rehabilitation strategies in brain injury.